GlobeStar Therapeutics Corporation
GSTC
$0.00
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -197.70K | -175.00K | -163.80K | -350.60K | -1.28M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 3.70K | 7.00K | 5.30K | 9.60K | 8.20K |
| Total Other Non-Cash Items | -13.30K | 23.60K | 25.00K | 108.50K | 1.12M |
| Change in Net Operating Assets | 186.80K | 132.00K | 90.70K | 159.80K | 115.00K |
| Cash from Operations | -20.40K | -12.40K | -42.80K | -72.70K | -40.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 25.40K | 3.90K | 25.30K | 40.70K | 18.00K |
| Total Debt Repaid | -5.00K | -9.00K | -- | 0.00 | -5.50K |
| Issuance of Common Stock | 0.00 | 17.50K | 17.50K | 32.00K | 27.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 20.40K | 12.40K | 42.80K | 72.70K | 40.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00 | -- | -- | 0.00 | -200.00 |